These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 639160)

  • 1. Biopharmaceutical study of the hepato-biliary transport of drugs. VII. Improvement of the bioavailability of rifampicin by dosage form design.
    Takada K; Mikami H; Asada S; Tatsuo K; Muranishi S
    Chem Pharm Bull (Tokyo); 1978 Jan; 26(1):19-24. PubMed ID: 639160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolism of rifampicin. I. Biliary and urinary excretion in normal rats and with experimental liver injury].
    Rodriguez Garay EA; Spetale MR; Morisoli LS; Rassero JA
    Farmaco Prat; 1973; 28(9):481-8. PubMed ID: 4751984
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepato-biliary effects of rifampicin in rats].
    Rozé C; Camilleri JP; Vaille C; Souchard M; Debray C
    Med Chir Dig; 1976 May; 5(6):373-7. PubMed ID: 1011900
    [No Abstract]   [Full Text] [Related]  

  • 4. Biopharmaceutical study of the hepato-biliary transport of drugs. I. Hepato-biliary transport of non-metabolizing organic anionic compounds in rat.
    Takada K; Mizobuchi Y; Muranishi S
    Chem Pharm Bull (Tokyo); 1974 Apr; 22(4):922-9. PubMed ID: 4420733
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic study of rifampicin in biliary surgery.
    Kiss IJ; Faragó E; Kiss B; Várhelyi I
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):105-9. PubMed ID: 649226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopharmaceutical study of the hepato-biliary transport of drugs. V. Hepatic uptake and biliary excretion of organic cations.
    Nakae H; Sakata R; Muranishi S
    Chem Pharm Bull (Tokyo); 1976 May; 24(5):886-93. PubMed ID: 1021272
    [No Abstract]   [Full Text] [Related]  

  • 7. Biopharmaceutical study of the hepato-biliary transport of drugs. II. Roles of the liver cytoplasmic Y and Z binding proteins and T binder on the hepato-biliary transport of organic anionic compounds.
    Takada K; Ueda M; Ono M; Muranishi S
    Chem Pharm Bull (Tokyo); 1974 Jul; 22(7):1477-86. PubMed ID: 4434573
    [No Abstract]   [Full Text] [Related]  

  • 8. Biopharmaceutical study of the hepato-biliary transport of drugs. IV. Development of the method to investigate the process of the active secretion of drugs from the hepatocytes into the bile canaliculi and its application to the biliary excretion of organic anions in rat.
    Takada K; Tokunaga Y; Muranishi S
    Chem Pharm Bull (Tokyo); 1976 May; 24(5):871-85. PubMed ID: 1021271
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolism of rifampicin. II. Distribution of rifampicin and its metabolites in normal rats and in rats with changes in the liver].
    Rodriguez Garay EA; Morisoli LS; Spetale MR; Rassero JA
    Farmaco Prat; 1973; 28(9):489-96. PubMed ID: 4751985
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum concentrations and biliary excretion of bilirubin during short-term treatment with rifampicin.
    Acocella G; Mattiussi R; Tenconi LT
    Tijdschr Gastroenterol; 1973; 16(3):186-90. PubMed ID: 4742768
    [No Abstract]   [Full Text] [Related]  

  • 11. Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms.
    Agrawal S; Panchagnula R
    Biopharm Drug Dispos; 2005 Nov; 26(8):321-34. PubMed ID: 16059874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Kinetics of rifampicin and desacetyl-rifampicin in plasma, bile, and urine in humans and the effect of repeated administrations.
    Acocella G; Segre G
    Acta Pharm Suec; 1974 Dec; 11(6):657-8. PubMed ID: 1136808
    [No Abstract]   [Full Text] [Related]  

  • 13. Choleretics and biliary excretion of antibiotics in rats.
    Coppi G; Monti L; Genova R
    Chemotherapy; 1971; 16(6):345-55. PubMed ID: 5004236
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifampicin Induces Bicarbonate-Rich Choleresis in Rats: Involvement of Anion Exchanger 2.
    Wang W; Ren X; Cai Y; Chen L; Zhang W; Xu J
    Dig Dis Sci; 2016 Jan; 61(1):126-36. PubMed ID: 26319954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies of the excretion of rifomycin in the bile].
    Nestle W
    Med Welt; 1969 Aug; 32():1741-3. PubMed ID: 5801060
    [No Abstract]   [Full Text] [Related]  

  • 16. [The importance of micronization in the design of dosage forms I. Theoretical and biopharmaceutical aspects].
    Antal I
    Acta Pharm Hung; 2006; 76(2):95-103. PubMed ID: 17094668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multicompartimental model for the study of drugs with high biliary excretion, used in the study of the kinetics of rifampicin in man].
    Acocella G; Pagani V; Nicolis FB
    Boll Chim Farm; 1972 Feb; 111(2):108-15. PubMed ID: 5045532
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bioavailability of 2 different rifampicin preparations].
    Aronne Benach MT; Naranjo Cascante G
    Rev Clin Esp; 1980 Oct; 159(1):43-6. PubMed ID: 7008102
    [No Abstract]   [Full Text] [Related]  

  • 19. Biopharmaceutical study of the hepato-biliary transport of drugs. VIII. Investigation of Hepatic uptake of organic cations by portal infusion.
    Nakae H; Iuchi Y; Muranishi S
    Chem Pharm Bull (Tokyo); 1978 Jan; 26(1):88-95. PubMed ID: 639168
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of presystemic factors on the oral bioavailability of rifampicin following multiple dosing.
    Zhang JN; Liu XG; Zhu M; Chiu FC; Li RC
    J Chemother; 1998 Oct; 10(5):354-9. PubMed ID: 9822352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.